Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Mylan Pharmaceuticals Recalls Two Drugs Due to Label Mixup, Could Pose Risk

By Pharmaceutical Processing | March 18, 2011

TORONTO
— Mylan Pharmaceuticals has started a voluntary recall of two drugs after a
pharmacist noticed a prescription product containing the wrong medication.

The products affected by the labelling error are one lot of
the Mylan-Minocycline 50-milligram capsules in bottles of 100, and
Mylan-Amlodipine five-milligram tablets in bottles of 100.

A patient who is taking Mylan-Amlodipine to treat high blood
pressure or angina could instead end up getting the other product, which is
used for skin infections, urinary tract infections, gallbladder infections, and
respiratory tract infections such as bronchitis, pneumonia and sinusitis.

A patient who is sensitive or allergic to tetracyclines or
minocyline could experience a life-threatening reaction. In addition, the
patient wouldn’t be getting the medication needed to control high blood
pressure or angina.

Health Canada
says the lot number of the recalled products is 1037180.

Mylan Pharmaceuticals says it received the pharmacist’s
complaint in mid-March.

“The pharmacist reported that she had ordered four
100-count bottles of Mylan-Minocycline 50 mg capsules, and had received instead
three Minocycline bottles correctly containing 100 Mylan-Minocycline 50 mg
capsules. However, the fourth bottle received as part of this order was
labelled as Mylan-Amlodipine 5mg Tablets, but contained 100 Mylan-Minocycline
50 mg capsules.”

The drug company says a quality investigation is continuing.

Health Canada
is monitoring the company’s recall.

 

Related Articles Read More >

Taro Pharmaceuticals announces Type I recall of Taro-zoledronic acid injection
Fresenius Kabi
Fresenius Kabi plans to add 2D barcodes to its pharmaceutical portfolio
analyzing medical sample
Expert answers to nitrosamine impurity questions
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards